BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25219946)

  • 1. Evaluation of the influence of ayurvedic formulation (Ayushman-15) on psychopathology, heart rate variability and stress hormonal level in major depression (Vishada).
    Kishore RK; Abhishekh HA; Udupa K; Thirthalli J; Lavekar GS; Gangadhar BN; Raju TR; Sathyaprabha TN
    Asian J Psychiatr; 2014 Dec; 12():100-7. PubMed ID: 25219946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
    Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability and treatment outcome in major depression: a pilot study.
    Jain FA; Cook IA; Leuchter AF; Hunter AM; Davydov DM; Ottaviani C; Tartter M; Crump C; Shapiro D
    Int J Psychophysiol; 2014 Aug; 93(2):204-10. PubMed ID: 24769434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.
    Han C; Wang SM; Kwak KP; Won WY; Lee H; Chang CM; Tang TC; Pae CU
    J Psychiatr Res; 2015; 66-67():84-94. PubMed ID: 26013203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in heart rate variability in first-episode drug-naïve adolescents with major depressive disorder: A 12-week prospective study.
    Park SW; Lee JH; Kim J; Suh S; Lee MS
    J Affect Disord; 2018 Oct; 238():250-255. PubMed ID: 29890452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive heart rate variability in male patients with first-episode major depressive disorder.
    Liang CS; Lee JF; Chen CC; Chang YC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():52-7. PubMed ID: 25149628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of depression and melatonergic antidepressant treatment alone and in combination with sedative-hypnotics on heart rate variability: Implications for cardiovascular risk.
    Chang CC; Tzeng NS; Yeh CB; Kuo TBJ; Huang SY; Chang HA
    World J Biol Psychiatry; 2018 Aug; 19(5):368-378. PubMed ID: 28281386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression.
    Hage B; Britton B; Daniels D; Heilman K; Porges SW; Halaris A
    World J Biol Psychiatry; 2019 Jun; 20(5):359-367. PubMed ID: 28895492
    [No Abstract]   [Full Text] [Related]  

  • 12. Mind and heart: heart rate variability in major depressive disorder and coronary heart disease - a review and recommendations.
    Stapelberg NJ; Hamilton-Craig I; Neumann DL; Shum DH; McConnell H
    Aust N Z J Psychiatry; 2012 Oct; 46(10):946-57. PubMed ID: 22528974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.
    Block T; Petrides G; Kushner H; Kalin N; Belanoff J; Schatzberg A
    J Clin Psychopharmacol; 2017 Oct; 37(5):505-511. PubMed ID: 28708736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cortisol concentration in patients with major depression after treatment with fluoxetine.
    Piwowarska J; Chimiak A; Matsumoto H; Dziklińska A; Radziwoń-Zaleska M; Szelenberger W; Pachecka J
    Psychiatry Res; 2012 Aug; 198(3):407-11. PubMed ID: 22429479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression.
    Ahrens T; Deuschle M; Krumm B; van der Pompe G; den Boer JA; Lederbogen F
    Psychosom Med; 2008 May; 70(4):461-7. PubMed ID: 18378864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overweight and obesity affect treatment response in major depression.
    Kloiber S; Ising M; Reppermund S; Horstmann S; Dose T; Majer M; Zihl J; Pfister H; Unschuld PG; Holsboer F; Lucae S
    Biol Psychiatry; 2007 Aug; 62(4):321-6. PubMed ID: 17241618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between symptoms of depression and heart rate variability: An exploratory study.
    Borrione L; Brunoni AR; Sampaio-Junior B; Aparicio LM; Kemp AH; Benseñor I; Lotufo PA; Fraguas R
    Psychiatry Res; 2018 Apr; 262():482-487. PubMed ID: 28958456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.
    Tanaka Y; Ishitobi Y; Maruyama Y; Kawano A; Ando T; Okamoto S; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):220-4. PubMed ID: 22063648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.